← Back to Search
The Hyaluronan Receptor (CD44) Participates In The Uptake And Degradation Of Hyaluronan
M. Culty, H. A. Nguyen, C. Underhill
Published 1992 · Biology, Medicine
Download PDFAnalyze on Scholarcy
The hyaluronan receptor belongs to the polymorphic family of CD44 glycoproteins, which have been implicated in a variety of cellular functions including adhesion to hyaluronan and collagen, the binding of lymphocytes to high endothelial cells during extravasation, and conferring metastatic potential to carcinoma cells. Here, we demonstrate that the receptor also participates in the uptake and degradation of hyaluronan by both transformed fibroblasts (SV-3T3 cells) and alveolar macrophages. These cells were incubated with isotopically labeled hyaluronan for various periods of time, and the extent of degradation was determined by either molecular-sieve chromatography or centrifugation through Centricon 30 microconcentrators. The macrophages degraded the hyaluronan at a faster rate than the SV-3T3 cells, which may reflect the fact that they contained a greater number of receptors. More importantly, in both cell types, the degradation of hyaluronan was specifically blocked by antibodies directed against the receptor. However, the receptor by itself did not have the ability to degrade hyaluronan, since preparations of SV-3T3 membranes containing the receptor did not break down hyaluronan. Subsequent experiments revealed that macrophages can internalize fluorescein-tagged hyaluronan, and this process was blocked by antibodies against the receptor. Furthermore, the subsequent degradation of hyaluronan was inhibited by agents that block the acidification of lysosomes (chloroquine and NH4Cl). Thus, the most likely explanation for these results is that the receptor mediates the uptake of hyaluronan into the cell where it can be degraded by acid hydrolases in lysosomes. The ability of cells expressing the receptor to degrade hyaluronan may be important during tissue morphogenesis and cell migration.
This paper references
C De Duve (1974)
A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family
I. Stamenković (1989)
Binding of hyaluronate and chondroitin sulphate to liver endothelial cells.
T. Laurent (1986)
Turnover and metabolism of hyaluronan.
J. E. Fraser (1989)
Aggregation of macrophages and fibroblasts is inhibited by a monoclonal antibody to the hyaluronate receptor.
S. J. Green (1988)
Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition
K. Miyake (1990)
The mucosal vascular addressin is a tissue-specific endothelial cell adhesion molecule for circulating lymphocytes
M. Nakache (1989)
Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1.
J. Lesley (1990)
Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin
E. Kalomiris (1988)
Size‐dependent hyaluronate degradation by cultured cells
P. G. Mcguire (1987)
Interaction of hyaluronate with the surface of SV- 3T3 cells : aggregation and binding studies
C Underhill (1982)
Physical characteristics of hyaluronate binding to the surface of simian virus 40-transformed 3T3 cells.
C. Underhill (1980)
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
U. Guenthert (1991)
A modified uronic acid carbazole reaction.
T. Bitter (1962)
Immunoaffinity isolation of membrane antigens with biotinylated monoclonal antibodies and streptavidin-agarose.
T. V. Updyke (1986)
Receptor-mediated endocytosis: concepts emerging from the LDL receptor system.
J. Goldstein (1985)
Isolation and characterization of hyaluronidase from cultures of chick embryo skin- and muscle-derived fibroblasts.
R. Orkin (1980)
Binding of hyaluronate to the surface of cultured cells
C. Underhill (1979)
The interaction of hyaluronate with the cell surface: the hyaluronate receptor and the core protein.
C. Underhill (1989)
Th e distribution of hyaluronate and hyaluronate receptors in the adult lungs
S J Green (1988)
Acidification of the endocytic and exocytic pathways.
I. Mellman (1986)
Dendritic Cells: Features and Functions
R. Steinman (1980)
The role of hyaluronic acid
Interaction of hyaluronate with the surface of SV3 T 3 cells : aggregation and binding studies
C. B. Underhill (1982)
The role of hyaluronic acid in intercellular adhesion of cultured mouse cells.
C. Underhill (1978)
Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver.
S. Eriksson (1983)
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
U. Laemmli (1970)
Receptors for hyaluronate on the surface of parent and virus-transformed cell lines: binding and aggregation studies.
C. Underhill (1981)
Hyaluronate degradation in 3T3 and simian virus-transformed 3T3 cells.
R. Orkin (1982)
The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins [published erratum appears in J Cell Biol 1991 Feb;112(3):following 513]
M. Culty (1990)
The hyaluronate receptor is preferentially expressed on proliferating epithelial cells
A. Alho (1989)
CD44 is the principal cell surface receptor for hyaluronate
A. Aruffo (1990)
Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells
S. Jalkanen (1987)
A tissue-specific endothelial cell molecule involved in lymphocyte homing
P. Streeter (1988)
Morphogenic role of glycosaminoglycans ( acid mucopolysaccharides ) in brain and other tissues
B. P. Toole (1976)
C. de Duve (1983)
Characterization and identification of the hyaluronate binding site from membranes of SV-3T3 cells.
C. Underhill (1985)
Affinity and distribution of surface and intracellular hyaluronic acid receptors in isolated rat liver endothelial cells.
R. Raja (1988)
Effects of detergent solubilization on the hyaluronate-binding protein from membranes of simian virus 40-transformed 3T3 cells.
C. Underhill (1983)
Enzymic pathways of hyaluronan catabolism.
L. Rodén (1989)
The hyaluronate receptor is identical to a glycoprotein of Mr 85,000 (gp85) as shown by a monoclonal antibody that interferes with binding activity.
C. Underhill (1987)
Uptake and degradation of hyaluronan in lymphatic tissue.
J. E. Fraser (1988)
The hyaluronate receptor is associated with actin filaments
B. Lacy (1987)
This paper is referenced by
Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activity.
K. Akima (1996)
Serglycin secreted by leukocytes is efficiently eliminated from the circulation by sinusoidal scavenger endothelial cells in the liver
I. Oynebraten (2000)
Effect of hyaluronic acid on development of in vitro produced bovine embryos.
C. Furnus (1998)
Localization of CD44 and hyaluronan in the synovial membrane of the rat temporomandibular joint.
A. Suzuki (2006)
Hydrogen Peroxide Responsive Iron-Based Nanoplatform for Multimodal Imaging-Guided Cancer Therapy.
P. Wang (2019)
CD44 targeted delivery of siRNA by using HA‐decorated nanotechnologies for KRAS silencing in cancer treatment
A. Tirella (2019)
Cancer Stem Cells Concise Review : Emerging Role of CD 44 in Cancer Stem Cells : A Promising Biomarker and Therapeutic Target
Yongmin Yan (2015)
Hyaluronidases and CD44 undergo differential modulation during chondrogenesis.
S. Nicoll (2002)
Coculture‐Driven Mesenchymal Stem Cell‐Differentiated Articular Chondrocyte‐Like Cells Support Neocartilage Development
Y. Yang (2012)
AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44.
R. Lamb (1997)
Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) invovement.
G. Lisignoli (2001)
Size-dependent regulation of Snail2 by hyaluronan: its role in cellular invasion.
Evisabel A Craig (2009)
CD44 expression in human bone: A novel marker of osteocytic differentiation
D. E. Hughes (1994)
Enzymatically Triggered in situ Gel-Forming Biomaterials for Regenerative Medicine
Yoon Ki Joung (2012)
Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer.
Shaheen Mahira (2019)
Expression of CD44 variants in human inflammatory synovitis
L. Hale (2005)
Ultrastructural Analysis of Human Epidermal CD44 Reveals Preferential Distribution on Plasma Membrane Domains Facing the Hyaluronan-rich Matrix Pouches
A. Tuhkanen (1998)
CD44H and the isoforms CD44v5 and CD44v6 in the synovial fluid of the osteoarthritic human knee joint.
S. Fuchs (2003)
Hyaluronic acid of high molecular weight inhibits proliferation and induces cell death in U937 macrophage cells.
Kyle M Sheehan (2004)
Catabolism of aggrecan proteoglycan aggregate components in short-term explant cultures of tendon.
S. Rees (2005)
Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
A. Yadav (2007)
Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
Kitae Park (2010)
Hyaluronan (HA) content, the ratio of HA fragments and the expression of CD44 in the ovine cervix vary with the stage of the oestrous cycle.
K. Perry (2010)
Aktivierung von humanen glatten Gefäßmuskelzellen durch Hyaluronsäure-Synthase 3: Bedeutung für die Pathogenese der Atherosklerose
B. Rabausch (2008)
Hyaluronan synthases, hyaluronan, and its CD44 receptor in tissue around loosened total hip prostheses
Y. Konttinen (2001)
Hyaluronic Acid and Derivatives for Tissue Engineering.
F. Menaa (2013)
Engineering proteolytically-degradable artificial extracellular matrices
Keila B. Fonseca (2014)
Supplementation of specific carbohydrates results in enhanced deposition of chondrogenic‐specific matrix during mesenchymal stem cell differentiation
Trudy Christiansen-Weber (2018)
Molecular and Cellular Aspects of Periimplantation Processes
S. K. Dey (1995)
Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development
A. Bartolazzi (1994)
Distribution of carbonic anhydrase IX, MN/CA IX, in normal and neoplastic gastrointestinal and hepatobiliary tissues : its potential value as a new biomarker and comparison of its expression with that of isoenzymes I, II, IV, V, and VI
J. Saarnio (2000)
CD44 immunoreactivity in the developing human kidney: a marker of renal progenitor stem cells?
D. Fanni (2013)See more